近年来发表文章（部分）

1. Li Y, Huang H, Liu B, Zhang Y, Pan X, Yu XY, Shen Z, Song YH. Inflammasomes as therapeutic targets in human diseases. Signal Transduction and Targeted Therapy, 2021; 6(1):247

2. Wang Y, Xie W, Liu B, Huang H, Luo W, Zhang Y, Pan X, Yu XY, Shen Z, Li Y. Stem cell-derived exosomes repair ischemic muscle injury by inhibiting the tumor suppressor Rb1-mediated NLRP3 inflammasome pathway. Signal Transduction and Targeted Therapy, 2021; 6:121

3. Li Y, Ding FZ, Shen ZY. Letter by Li et al Regarding Article, “Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice”. Circulation, 2020; 142(7): e95–e96

4.Yan B, Zhang Y, Liang C, Liu B, Ding FZ, Wang YL, Zhu B, Zhao RZ, Yu XY, Li Y. Stem cell-derived exosomes prevent pyroptosis and repair ischemic muscle injury through a novel exosome/circHIPK3/ FOXO3a pathway.Theranostics, 2020; 10(15): 6728-6742.

5. Zhang Y, Wang Y, Shao L, Pan X, Liang C, Liu B, Zhang Y, Xie W, Yan B, Liu F, Yu XY, Li Y. Knockout of beta-2 microglobulin reduces stem cell-induced immune rejection and enhances ischemic hindlimb repair via exosome/miR-24/Bim pathway. J of Cellular and Molecular Medicine, 2020; 24(1):695-710.

6. Li Y, Shen ZY, Yu XY. Letter Regarding Article, Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration. Circulation, 2019; 140(5):e177-e178.

7. Shao LB, Zhang Y, Pan XB, Liu B, Liang C, ZhangYQ, Wang YL, Yan B, Xie WP, Sun Y, Shen ZY, Yu XY, Li Y. Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection. Cellular and Molecular Life Sciences, 2020, 77(5):937-952.

8. Han CS, Zhou J, Liu B, Liang C, Pan XB, Zhang Y, Zhang YQ, Wang YL, Shao LB, Zhu B, Wang JJ, Yin Q, Yu XY, Li Y. Delivery of miR-675 by stem cell-der ived exosomes encapsulated in silk fibroin hydrogel prevents aging-induced vascular dysfunction in mouse hindlimb. Materials Science & Engineering C, 2019; 99:322-332.

9. Han CS, Zhou J, Liu B, Liang C, Liu B, Pan XB, Zhang Y, Wang YL, Yan B, Xie WP, Liu F, Yu XY, Li Y. Human umbilical cord mesenchymal stem cell derived exosomes encapsulated in functional peptide hydrogels promote cardiac repair. Biomaterials Science, 2019; 7(7):2920-2933.

10. Zhu B, Zhang L, Liang C, Liu B, Pan X, Wang Y, Zhang YQ, Zhang Y, Xie W, Yan B, Liu F, Yip H, Yu XY, Li Y. Stem Cell-Derived Exosomes Prevent Aging-Induced Cardiac Dysfunction through Novel Exosome/LncRNA MALAT1/NF-κB/TNF-α Signaling Pathway. Oxidative Medicine and Cellular Longevity , 2019; Article ID 9739258.

11. Li Y, Liu B and Liang C. Letter by Li et al Regarding Article, Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling. Circulation. 2017; 136: 2092-2093.

12. Li Y, Zhou J, Song YH, Yu XY. Dominant and recessive imprinting of exosomes from parent cells. Nature Reviews Cardiology, 2017, 14(8): 491.

13. Shao L, Zhang Y, Lan B, Wang J, Zhang Z, Zhang L, Xiao P, Meng Q, Geng YJ, Yu XY and Li Y. MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair. Biomed Res Int. 2017; 2017: 4150705.

14. Shen C, Zhou J, Wang X, Yu XY, Liang C, Liu B, Pan X, Zhao Q, Song JL, Wang J, Bao M, Wu C, Li Y and Song YH. Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3beta Signaling Pathway. EBioMedicine. 2017; 16: 238-250.

15. Li Y, Song YH, Liu B and Yu XY. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research. Int J Cardiol. 2017; 227: 191-193.

16. Li Y, Song YH and Yu XY. Letter by Li et al Regarding Article, MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. Circulation. 2016; 133: e713.

17. Zhou J, Liu B, Liang C, Li Y and Song YH. Cytokine Signaling in Skeletal Muscle Wasting. Trends Endocrinol Metab. 2016; 27: 335-347.

18. Li Y, Shen Z and Yu XY. Transport of microRNAs via exosomes. Nat Rev Cardiol. 2015; 12: 198.

申请专利（已公示部分）

1.  CRISPR技术编辑并用IGF优化的异体间充质干细胞的制备方法及在治疗心梗中应用，发明人：李杨欣；沈振亚；邵联波，专利号：ZL 2016 1 0297972.0（已授权）

2.  间充质干细胞分泌的外泌小体治疗心肌梗死的新用途，发明人：李杨欣，申请公布号：CN105395571A

3. 多肽、重组DNA分子、重组载体、外泌体及其应用，发明人：李杨欣；邵联波；沈振亚，专利号：ZL 2018 1 0447876.9（已授权）

4. 一种缓释外泌体的多肽纳米纤维水凝胶及其制备方法与应用，发明人：李杨欣；韩超珊，申请公布号：CN108853147A

5.丝素水凝胶包裹的过表达ncRNA的MSC外泌体制备方法与在抗后肢衰老中的应用,发明人：李杨欣；韩超珊，  申请公布号：CN110144324A

6. 一种带有母系印记的温敏感外泌体体系及其制备方法和应用，发明人：李杨欣；刘冯；沈振亚；张瑜，申请公布号：CN111450117A

基金支持

1. 国自然基金面上项目

2. 国自然基金重大研究（培育）项目

3. 江苏省“六大人才高峰”创新团队

4.  江苏省双创团队

5.  江苏省重点研发计划（社会发展）项目

6.  苏州市民生科技项目

7.  苏州市高等院校、科研院所紧缺高层次人才

8.  江苏省双创人才计划项目

7.  苏州大学启动经费